IBDEI3AF ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52470,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,52471,0)
 ;;=E10.41^^194^2539^7
 ;;^UTILITY(U,$J,358.3,52471,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52471,1,3,0)
 ;;=3^DM Type 1 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,52471,1,4,0)
 ;;=4^E10.41
 ;;^UTILITY(U,$J,358.3,52471,2)
 ;;=^5002605
 ;;^UTILITY(U,$J,358.3,52472,0)
 ;;=E10.42^^194^2539^11
 ;;^UTILITY(U,$J,358.3,52472,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52472,1,3,0)
 ;;=3^DM Type 1 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52472,1,4,0)
 ;;=4^E10.42
 ;;^UTILITY(U,$J,358.3,52472,2)
 ;;=^5002606
 ;;^UTILITY(U,$J,358.3,52473,0)
 ;;=E10.43^^194^2539^2
 ;;^UTILITY(U,$J,358.3,52473,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52473,1,3,0)
 ;;=3^DM Type 1 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,52473,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,52473,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,52474,0)
 ;;=E10.44^^194^2539^1
 ;;^UTILITY(U,$J,358.3,52474,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52474,1,3,0)
 ;;=3^DM Type 1 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,52474,1,4,0)
 ;;=4^E10.44
 ;;^UTILITY(U,$J,358.3,52474,2)
 ;;=^5002608
 ;;^UTILITY(U,$J,358.3,52475,0)
 ;;=E10.49^^194^2539^25
 ;;^UTILITY(U,$J,358.3,52475,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52475,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,52475,1,4,0)
 ;;=4^E10.49
 ;;^UTILITY(U,$J,358.3,52475,2)
 ;;=^5002609
 ;;^UTILITY(U,$J,358.3,52476,0)
 ;;=E10.59^^194^2539^22
 ;;^UTILITY(U,$J,358.3,52476,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52476,1,3,0)
 ;;=3^DM Type 1 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,52476,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,52476,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,52477,0)
 ;;=E10.610^^194^2539^9
 ;;^UTILITY(U,$J,358.3,52477,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52477,1,3,0)
 ;;=3^DM Type 1 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,52477,1,4,0)
 ;;=4^E10.610
 ;;^UTILITY(U,$J,358.3,52477,2)
 ;;=^5002613
 ;;^UTILITY(U,$J,358.3,52478,0)
 ;;=E10.618^^194^2539^23
 ;;^UTILITY(U,$J,358.3,52478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52478,1,3,0)
 ;;=3^DM Type 1 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,52478,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,52478,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,52479,0)
 ;;=E10.630^^194^2539^30
 ;;^UTILITY(U,$J,358.3,52479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52479,1,3,0)
 ;;=3^DM Type 1 w/ Peridontal Disease
 ;;^UTILITY(U,$J,358.3,52479,1,4,0)
 ;;=4^E10.630
 ;;^UTILITY(U,$J,358.3,52479,2)
 ;;=^5002619
 ;;^UTILITY(U,$J,358.3,52480,0)
 ;;=E10.638^^194^2539^27
 ;;^UTILITY(U,$J,358.3,52480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52480,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,52480,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,52480,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,52481,0)
 ;;=E10.641^^194^2539^15
 ;;^UTILITY(U,$J,358.3,52481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52481,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,52481,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,52481,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,52482,0)
 ;;=E10.649^^194^2539^16
 ;;^UTILITY(U,$J,358.3,52482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52482,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,52482,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,52482,2)
 ;;=^5002622
